These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1071402)

  • 1. Once daily dosage beta-blockade: antihypertensive efficacy of slow release oxprenolol as related to renin and age.
    Bühler FR; Lütold BE; Küng M; Koller FJ
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):37-43. PubMed ID: 1071402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M; Fusco M; Valente D
    G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise and resting blood pressure and heart rate changes 24 h after dosing in patients with essential hypertension receiving 16/260 oxprenolol Oros once daily.
    Müller FB; Allsopp LF; Cooper GL; Bolli P; Frei P; Glaus L; Ritz R; Bühler FR
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):207S-212S. PubMed ID: 4005124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
    Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M
    Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a slow-release formulation of oxprenolol.
    Waal-Manning HJ; Spears GF
    N Z Med J; 1978 Apr; 87(609):245-6. PubMed ID: 275650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a slow-release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():559s-561s. PubMed ID: 1071681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a slow release formulation of oxprenolol with conventional oxprenolol in the treatment of hypertension.
    O'Brien KP; Stephens EJ
    N Z Med J; 1976 Aug; 84(570):142-4. PubMed ID: 1069924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre evaluation of sustained release oxprenolol in the management of hypertension in hospital out-patient practice.
    Forrest WA
    J Int Med Res; 1978; 6(2):136-40. PubMed ID: 631415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
    Bühler FR; Burkart F; Lütold BE; Küng M; Marbet G; Pfisterer M
    Am J Cardiol; 1975 Oct; 36(5):653-69. PubMed ID: 242209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
    Resnekov EB; Havard CW
    Eur J Clin Pharmacol; 1978 Nov; 14(2):77-81. PubMed ID: 363434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interrelationships between renin and arterial pressure in subjects with essential hypertension under diuretic treatment: effect of addition of oxprenolol and indomethacin].
    Pedrinelli R; Cavasinni L; Poli L; Salvetti A
    Boll Soc Ital Cardiol; 1978; 23(8):1327-33. PubMed ID: 398710
    [No Abstract]   [Full Text] [Related]  

  • 13. Once daily administration of a beta-blocker in hypertension.
    Watt M; Duncan TD
    N Z Med J; 1978 Feb; 87(606):126-8. PubMed ID: 274648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A; Tomasi AM; Pirani R; Lazzaretto R; Ambroso G
    G Ital Cardiol; 1981; 11(12):2105-9. PubMed ID: 7346306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the beta-adrenoceptor blocking activity of oxprenolol, slow release oxprenolol and a combined oxprenolol diuretic preparation.
    Kerr MJ; Harron DW; Kinney C; Shanks RG
    Br J Clin Pharmacol; 1981 Dec; 12(6):869-71. PubMed ID: 6122463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute combined alpha- and beta-adrenergic blockade in essential hypertension: effects on blood pressure, renal function, renin, and aldosterone].
    Grüninger U; Akert R; Hunkeler H; Wegmüller E; Weidmann P; Hodler J
    Klin Wochenschr; 1979 Jul; 57(14):731-9. PubMed ID: 470335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
    Forrest WA
    Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow release oxprenolol in angina pectoris: study comparing oxprenolol, once daily, with propranolol, four times daily.
    Olowoyeye JO; Thadani U; Parker JO
    Am J Cardiol; 1981 May; 47(5):1123-7. PubMed ID: 7223659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once daily beta-blocker in hypertension--oxprenolol slow-release.
    Gordon RD; Ziesak M; Rowe WS; Strakosch CR; Row G
    J Int Med Res; 1981; 9(1):6-11. PubMed ID: 7009256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.